Edarbi approved for treatment of hypertension - ONA
Links shared publicly online about this topic.
- 473total visits
Edarbi approved for treatment of hypertension - ONA
View full resource at oncologynurseadvisor.com
Tags: Heart Disease, High Blood Pressure, Pharma, FDA
Most Recently Shared on February 28, 2011 at 3:40 pm By:
Edarbi approved for treatment of hypertension http://goo.gl/fb/pfChq
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine - QualityPoint Technologies
qualitypointtech.net — “The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone has an insufficient effect. In an early benefit assessment pursuant to the” View full resource at qualitypointtech.net
Most Recently Shared on March 25, 2012 at 11:00 am By:
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine: The fixed drug combination of aliskiren and aml... http://t.co/3t61fV6F
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine
medicalnewstoday.com — “The fixed drug combination of aliskiren and amlodipine (trade name: Rasilamlo®) was approved in April 2011 for the treatment of people with hypertension in whom aliskiren or amlodipine alone h” View full resource at medicalnewstoday.com
Most Recently Shared on March 25, 2012 at 7:05 am By:
No Added Benefit Found For Fixed Combination Aliskiren/Amlodipine http://t.co/LloszBoY #hypertension
Edarbyclor Approved for Hypertension - MPR
empr.com — “Takeda announced that the FDA has approved Edarbyclor (azilsartan medoxomil and chlorthalidone) for the treatment of hypertension in adults.” View full resource at empr.com
Most Recently Shared on December 21, 2011 at 7:02 pm By:
Edarbyclor Approved for #Hypertension http://t.co/27BgJed9 #cardiology #cardiovascular
TWYNSTA™ For Controlling Hypertension Approved By Health Canada
medicalnewstoday.com — “Health Canada has approved TWYNSTA™ (telmisartan and amlodipine) for the treatment of mild to moderate essential hypertension (when the cause of high blood pressure is unknown) in individual” View full resource at medicalnewstoday.com
Most Recently Shared on October 7, 2011 at 12:05 pm By:
MNT Drug Approvals Health News
TWYNSTA™ For Controlling Hypertension Approved By Health Canada http://mnt.to/429j #regulatory
CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension
news-medical.net — “CVRx, Inc., a private medical device company, introduced today its second-generation implantable device, the Barostim neo, for the treatment of uncontrolled hypertension. The Barostim neo features a new unilateral, 1mm electrode and a new smaller, more advanced stimulator to allow for more focused and efficient delivery of therapy. These improvements have led to shorter procedure times and extended longevity.” View full resource at news-medical.net
Most Recently Shared on August 25, 2011 at 1:17 pm By:
CVRx introduces CE Mark approved Barostim neo for treatment of uncontrolled hypertension: CVRx, Inc., a private ... http://t.co/mER5QQs
FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension
news-medical.net — “Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.” View full resource at news-medical.net
Most Recently Shared on July 12, 2011 at 6:46 am By:
Stroke News: FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension: Medtronic, ... http://twurl.nl/wwvm6n
Phase 3 Studies of Azilsartan Medoxomil Plus Chlorthalidone for Hypertension - MPR
empr.com — “Takeda Global Research & Development Center, Inc. announced results from three Phase 3 studies of azilsartan medoxomil (Edarbi; Takeda Pharmaceuticals North America) plus chlorthalidone for the treatment of hypertension.” View full resource at empr.com
Most Recently Shared on May 23, 2011 at 5:40 pm By:
MPR News: Phase 3 Studies of Azilsartan Medoxomil Plus Chlorthalidone for Hypertension: Takeda Global Research &... http://bit.ly/lgbIQ5
Pfizer's Revatio extends Europe PAH licence | InPharm
inpharm.com — “Pfizer--™s Revatio has been approved by European regulators for the treatment of pulmonary arterial hypertension (PAH) in children” View full resource at inpharm.com
Most Recently Shared on May 9, 2011 at 11:54 am By:
Pharmafocus Pharma and Health News
Pfizer's Revatio extends Europe PAH licence http://goo.gl/fb/EsYqT
Edarbi Available for Hypertension - MPR
empr.com — “Edarbi (azilsartan medoxomil tablets; Takeda) is available for the treatment of hypertension in adults.” View full resource at empr.com
Most Recently Shared on April 15, 2011 at 2:07 pm By:
MPR News: Edarbi Available for Hypertension: Edarbi (azilsartan medoxomil tablets; Takeda) is available for the ... http://bit.ly/fGia2k
FDA approves change to prescribing information for Gilead Sciences' Letairis
news-medical.net — “Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration has approved a change to the prescribing information for Letairis (ambrisentan 5 mg and 10 mg tablets), the company's once-daily treatment to improve exercise ability and delay clinical worsening in pulmonary arterial hypertension (PAH, WHO Group 1) patients with predominantly WHO Functional Class II-III symptoms.” View full resource at news-medical.net
Most Recently Shared on March 5, 2011 at 12:03 pm By:
Pregnancy News: FDA approves change to prescribing information for Gilead Sciences' Letairis: Gilead Sciences, I... http://bit.ly/hi39GH
Azilsartan tablets approved to treat hypertension
endocrinetoday.com — “The FDA has announced the approval of azilsartan medoxomil, an angiotensin II receptor blocker, for the treatment of hypertension in adults.” View full resource at endocrinetoday.com
Most Recently Shared on March 1, 2011 at 4:44 pm By:
Azilsartan tablets approved to treat hypertension http://bit.ly/if7jd0
NursingCenter
nursingcenter.com — “. NursingCenter.com... Over 900 CE activities and thousands of clinical articles from over 50 leading Lippincott Williams & Wilkins nursing journals, including: The American Journal of Nursing, Nursing2007, Nursing Management, The Nurse Practitioner, Nursing Made Incredibly Easy, and many more specialty journals.” View full resource at nursingcenter.com
Most Recently Shared on March 1, 2011 at 3:13 pm By:
Lisa Morris Bonsall Advanced Practice Nurse and Nurse
Edarbi (azilsartan medoxomil) approved by the U.S. FDA to treat adults with hypertension http://bit.ly/ekrdQX
FDA Approves Edarbi to Treat High Blood Pressure
drugs.com — “Edarbi (azilsartan medoxomil) is used to treat high blood pressure (hypertension). Includes Edarbi side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 28, 2011 at 11:10 pm By:
FDA Approves Edarbi to Treat High Blood Pressure - http://bit.ly/fSAJSG
FDA Approves Edarbi to Treat High Blood Pressure
drugs.com — “Edarbi (azilsartan medoxomil) is used to treat high blood pressure (hypertension). Includes Edarbi side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 28, 2011 at 11:04 pm By:
Drugs and Devices OW OW Health
FDA Approves Edarbi to Treat High Blood Pressure: ROCKVILLE, MD., Feb. 25, 2011--The U.S. Food and Drug Ad... http://bit.ly/fSTEua #drug
Edarbi Approved for High Blood Pressure - Drugs.com MedNews
drugs.com — “Edarbi (azilsartan medoxomil) has been approved by the U.S. Food and Drug Administration to treat adults with high blood pressure (hypertension). Clinical trial” View full resource at drugs.com
Most Recently Shared on February 28, 2011 at 6:13 pm By:
Drugs and Devices OW OW Health
Edarbi Approved for High Blood Pressure: MONDAY, Feb. 28 -- Edarbi (azilsartan medoxomil) has been approve... http://bit.ly/go8tZf #drug
Advertisement
